Matches in Wikidata for { <http://www.wikidata.org/entity/Q62608155> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q62608155 description "article published in 2018" @default.
- Q62608155 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62608155 description "wetenschappelijk artikel" @default.
- Q62608155 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q62608155 name "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 name "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 type Item @default.
- Q62608155 label "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 label "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 prefLabel "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 prefLabel "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 P1433 Q62608155-FDAC3D1C-E83C-4A67-9C89-A084CD29ED05 @default.
- Q62608155 P1476 Q62608155-47E46D04-B0A2-42DF-9FBB-384D2074A89D @default.
- Q62608155 P2093 Q62608155-09E3706C-2973-4456-8DF2-23CB747D1393 @default.
- Q62608155 P2093 Q62608155-6302FE0C-07F9-4B76-AF16-21609E9F3066 @default.
- Q62608155 P2093 Q62608155-72785C5D-CEA9-42FF-BB16-A71F3D134B15 @default.
- Q62608155 P2093 Q62608155-8AA67623-194F-4734-9A73-9ACA7C69CEA1 @default.
- Q62608155 P2093 Q62608155-C770B5BB-4440-492A-AFF2-5CC3087DDD63 @default.
- Q62608155 P304 Q62608155-26E6D880-9D6E-4CCD-AC5B-3793AF1359C3 @default.
- Q62608155 P31 Q62608155-FB17D1E5-1FD8-407D-9FD8-EA9D447FBA2C @default.
- Q62608155 P356 Q62608155-0D5AF5F0-6A57-4F28-9CF3-BF31C8FB5836 @default.
- Q62608155 P433 Q62608155-BEED2FB6-18EE-44F0-8F75-2AA37658799A @default.
- Q62608155 P478 Q62608155-431C91B7-BBFD-4AFC-ABDB-F76CC7FC713A @default.
- Q62608155 P577 Q62608155-3CEE3617-4ED2-4C35-97D1-E32C0044F50C @default.
- Q62608155 P921 Q62608155-E979D1FF-7362-480B-8245-C4ADB3974628 @default.
- Q62608155 P356 ACS.CGD.8B01413 @default.
- Q62608155 P1433 Q3005997 @default.
- Q62608155 P1476 "Combined Virtual/Experimental Multicomponent Solid Forms Screening of Sildenafil: New Salts, Cocrystals, and Hybrid Salt–Cocrystals" @default.
- Q62608155 P2093 "Anant Paradkar" @default.
- Q62608155 P2093 "Christopher A. Hunter" @default.
- Q62608155 P2093 "Mercè Font-Bardia" @default.
- Q62608155 P2093 "Rafael Barbas" @default.
- Q62608155 P2093 "Rafel Prohens" @default.
- Q62608155 P304 "7618-7627" @default.
- Q62608155 P31 Q13442814 @default.
- Q62608155 P356 "10.1021/ACS.CGD.8B01413" @default.
- Q62608155 P433 "12" @default.
- Q62608155 P478 "18" @default.
- Q62608155 P577 "2018-10-30T00:00:00Z" @default.
- Q62608155 P921 Q5139913 @default.